Stockreport

Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test

Tempus AI, Inc. - Class A  (TEM) 
PDF IPS test validation study data will be unveiled at the 2024 SITC Annual Meeting CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading [Read more]